You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 12, December 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Obsessive-Compulsive Disorder With Clomipramine and Desipramine in Children and Adolescents

A Double-blind Crossover Comparison

Henrietta L. Leonard, MD; Susan E. Swedo, MD; Judith L. Rapoport, MD; Elisabeth V. Koby, MD; Marge C. Lenane, MSW; Deborah L. Cheslow; Susan D. Hamburger, MA

Arch Gen Psychiatry. 1989;46(12):1088-1092.


Abstract

• Forty-eight children and adolescents with severe primary obsessive-compulsive disorder completed a 10-week doubleblind crossover trial of clomipramine hydrochloride (mean dose [±SD], 150±53 mg/d) and desipramine hydrochloride (mean dose [±SD], 153±55 mg/d). Clomipramine was clearly superior to desipramine in significantly reducing obsessive-compulsive symptoms. Age at onset, duration and severity of illness, type of symptom, and plasma drug concentrations did not predict clinical response to clomipramine. Sixty-four percent of patients who received clomipramine as their first active treatment showed at least some sign of relapse during desipramine treatment. We further document the specificity of the antiobsessional effect of clomipramine and the need for maintenance treatment.



Author Affiliations

From the Child Psychiatry Branch, National Institute of Mental Health, Bethesda, Md.


Footnotes

Accepted for publication November 11, 1988.

Preliminary results were presented at the New Clinical Drug Evaluation Unit Program in Key Biscayne, Fla, May 31, 1987, and in the proceedings published in Psychopharmacol Bull. 1988;24:93-95.

Reprint requests to the Child Psychiatry Branch, Bldg 10, Room 6N-240, National Institute of Mental Health, Bethesda, MD 20892 (Dr Leonard).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

References
APPI Online CME 2007;2007:2-2.
FULL TEXT  

Obsessive-Compulsive Disorder in Tourette Syndrome
Goodman et al.
J Child Neurol 2006;21:704-714.
ABSTRACT  

PET Imaging of Serotonin Transporters with [11C]DASB: Test-Retest Reproducibility Using a Multilinear Reference Tissue Parametric Imaging Method
Kim et al.
JNM 2006;47:208-214.
ABSTRACT | FULL TEXT  

Which SSRI? A Meta-Analysis of Pharmacotherapy Trials in Pediatric Obsessive-Compulsive Disorder
Geller et al.
Am. J. Psychiatry 2003;160:1919-1928.
ABSTRACT | FULL TEXT  

Multicenter Double-blind Comparison of Sertraline and Desipramine for Concurrent Obsessive-Compulsive and Major Depressive Disorders
Hoehn-Saric et al.
Arch Gen Psychiatry 2000;57:76-82.
ABSTRACT | FULL TEXT  

Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder: A Multicenter Randomized Controlled Trial
March et al.
JAMA 1998;280:1752-1756.
ABSTRACT | FULL TEXT  

Child Psychopharmacology Comes of Age
Rapoport
JAMA 1998;280:1785-1786.
FULL TEXT  

Double-blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-compulsive Disorder
Greist et al.
Arch Gen Psychiatry 1995;52:289-295.
ABSTRACT  

Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine
Altemus et al.
Arch Gen Psychiatry 1994;51:794-803.
ABSTRACT  

A Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-compulsive Disorder
Tollefson et al.
Arch Gen Psychiatry 1994;51:559-567.
ABSTRACT  

Tryptophan Depletion in Patients With Obsessive-Compulsive Disorder Who Respond to Serotonin Reuptake Inhibitors
Barr et al.
Arch Gen Psychiatry 1994;51:309-317.
ABSTRACT  

A 2- to 7-Year Follow-up Study of 54 Obsessive-Compulsive Children and Adolescents
Leonard et al.
Arch Gen Psychiatry 1993;50:429-439.
ABSTRACT  

A Double-blind Comparison of Clomipramine, Desipramine, and Placebo in the Treatment of Autistic Disorder
Gordon et al.
Arch Gen Psychiatry 1993;50:441-447.
ABSTRACT  

Caudate Glucose Metabolic Rate Changes With Both Drug and Behavior Therapy for Obsessive-Compulsive Disorder
Baxter et al.
Arch Gen Psychiatry 1992;49:681-689.
ABSTRACT  

Psychodermatology: Practical Guidelines on Pharmacotherapy
Koo and Pham
Arch Dermatol 1992;128:381-388.
ABSTRACT  

Cerebrospinal Fluid Neurochemistry in Children and Adolescents With Obsessive-Compulsive Disorder
Swedo et al.
Arch Gen Psychiatry 1992;49:29-36.
ABSTRACT  

A Double-blind Desipramine Substitution During Long-term Clomipramine Treatment in Children and Adolescents With Obsessive-Compulsive Disorder
Leonard et al.
Arch Gen Psychiatry 1991;48:922-927.
ABSTRACT  

A Double-blind Comparison of Clomipramine and Desipramine Treatment of Severe Onychophagia (Nail Biting)
Leonard et al.
Arch Gen Psychiatry 1991;48:821-827.
ABSTRACT  

Clomipramine in the Treatment of Patients With Obsessive-Compulsive Disorder
The Clomipramine Collaborative Study Group
Arch Gen Psychiatry 1991;48:730-738.
ABSTRACT  

Attention Deficit Hyperactivity Disorder: The Differential Diagnosis
Weinberg and Emslie
J Child Neurol 1991;6:S23-S36.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.